[1]龚卫锋,张养民.丙型肝炎不同基因型G蛋白偶联胆汁酸受体1含量变化及原因研究*[J].陕西医学杂志,2019,(9):1126-1129.
 GONG Weifeng,ZHANG Yangmin..Changes of GPBAR1 in different genotypes of hepatitis c and its causes[J].,2019,(9):1126-1129.
点击复制

丙型肝炎不同基因型G蛋白偶联胆汁酸受体1含量变化及原因研究*
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2019年9期
页码:
1126-1129
栏目:
基础研究
出版日期:
2019-09-05

文章信息/Info

Title:
Changes of GPBAR1 in different genotypes of hepatitis c and its causes
文章编号:
DOI:〖HT5K〗10.3969/j.issn.10007377.2019.09.006
作者:
龚卫锋张养民
西安市中心医院输血科(西安710003)
Author(s):
GONG WeifengZHANG Yangmin.
Transfusion Department of Xi’an Central Hospital (Xi’an 710003)
关键词:
丙型肝炎G蛋白偶联胆汁酸受体1原因基因分型
Keywords:
Key words 〖WT5BZ〗〖HT5”SS〗Hepatitis CG protein coupled bile acid receptor 1ReasonGenotyping
分类号:
R512.63
文献标志码:
A
摘要:
摘 要 〖HT5K〗目的: 分析陕西省内医院就诊患者中基因分布情况以及对不同基因型进行病情严重程度分析,比较丙肝不同基因型GPBAR1受体含量变化及原因。方法:对就诊的679例丙肝阳性患者中的362例丙肝分型阳性患者进行基因含量、肝功能指标和病情严重程度分析,采用ELISA方法检测不同基因型患者血清中的GPBAR1含量。结果:14例Ia型和159例Ib型初期症状较轻,37例甚至到肝硬化失代偿期才被发现;144例Ⅱa型初期症状较重。胆汁酸受体I含量1a﹑1b和2a型结果明显高于3a 、3b型和6a型(P<0.05﹚。丙肝患者治疗前后丙肝基因含量比较有统计学差异(P<0.05﹚。丙肝不同亚型病情严重程度比较有统计学差异 (P<0.05﹚。362例不同基因型结果比较有统计学差异(P<0.05)。结论:陕西省内丙肝患者以Ib型和Ⅱa型为主,分型结果与患者病情严重程度以及病情进程发展有较大关系。患者接受治疗后遏制了丙肝基因的复制,胆汁酸受体I含量在判断基因型严重程度和个体严重程度上有重要意义。不同基因型患者,因病毒不同分型对肝脏损害程度不同,所以可反映炎性指标的GPBAR1受体含量结果也有明显区别。
Abstract:
Abstract 〖WT5BZ〗〖HT5”SS〗Objective:To analyze the gene distribution and severity of different genotypes in patients attending hospital in shaanxi province,and to compare the changes and causes of GPBAR1 receptor in different genotypes of hepatitis c. Methods:362 of the 679 patients with positive hepatitis c were analyzed for gene content,liver function index and severity of the disease. ELISA was used to detect the content of GPBAR1 in the sera of patients with different genotypes. Results:14 cases of type Ia and 159 cases of type Ib had mild initial symptoms,and 37 cases were not detected until the decompensated stage of cirrhosis. 144 cases of Ⅱ type a heavier early symptoms. Bile acid receptor I levels 1a,1b and 2a showed significantly higher results than 3a,3b and 6a (P<0.05).Before and after the treatment of HCV patients there were statistical differences in HCV gene content(P<0.05). There were statistically significant differences in the severity of different subtypes of hepatitis c (P<0.05). The results of 362 cases with different genotypes were statistically different (P<0.05). Conclusion:Hepatitis c patients in Shaanxi province is given priority to with Ib and Ⅱa type,the classification results and the disease severity and patient process development has great relationship. After treatment,the replication of HCV gene was inhibited in patients,and the bile acid receptor I content was important in determining genotype severity and individual severity. In patients with different genotypes,the level of GPBAR1 receptor,which can reflect inflammatory indicators,was significantly different due to the degree of liver damage caused by different virus types.

参考文献/References:

[1] 〖ZK(#〗唐 芬,汤桂芳,龚星光,等.聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎疗效观察及影响因素分析[J] .陕西医学杂志,2016,45(7):894896.
[2] 付汉东,张爱华,胡校云,等.孝感地区丙型肝炎病毒基因分型特点与临床意义[J] .中华医院感染学杂志,2016,20:46054607.
[3] 林 江,温先勇,唐 敏.川南地区丙型肝炎基因型的特征及其临床价值[J] .四川医学,2016,12:13481351.
[4] 刘 涛,陈兆云,张朝霞.新疆地区维族与汉族丙型肝炎患者HCV基因分型研究[J] .中华医院感染学杂志,2015,18:41224124.
[5] 胡大山,赵 伟,薛 蓉,等.南京与广东两地丙型肝炎215例基因分型与感染途径分析[J] .江苏医药,2014,5:597598.
[6] 尚明金,李连友,李连兴.赤峰地区丙肝基因分型及其临床意义分析[J] .中国卫生标准管理杂志,2017,8:34.
[7] 谢知兵,周建亮,李勇忠,等.怀化地区丙肝基因分型分布及临床意义[J] .中国现代医学杂志,2013,11:4346.
[8] 龚卫锋,张养民,张砚敏.妇科肿瘤患者血清人G蛋白胆汁酸受体1水平变化及其相关性探讨[J] .陕西医学杂志,2017,46(9):13121313.
[9] Biagioli M,Carino A,Cipriani S,et al.The bile acid receptor GPBAR1 regulates the M1/M2 Phenotype of Intestinal macrophages and activation of GPBAR1 rescues mice from murine colitis[J] . Journal of Immunology,2017,199(2):718733.〖ZK)〗
[10] 〖ZK(#〗Finamore C,Festa C,Renga B,et al.Navigation in bile acid chemical space:discovery of novel FXR and GPBAR1 ligands[J] .Scientific Reports,2016,(29):320321.
[11] Lou GU,Ma XX,Fu XH,et al.GPBAR1/TGR5 mediates bile acidinduced cytokine expression in murine Kupffer cells[J] .PloS one,2014,9(4):e9356793568.
[12] 胡大山,赵 伟,薛 蓉,等.南京与广东两地丙型肝炎215例基因分型与感染途径分析[J] .江苏医药,2014,40(5):597598.
[13] 崔利利,苏 斌,程晓莉,等.安徽省医疗机构丙型肝炎诊断能力及其对病例报告的影响[J] .中华疾病控制杂志,2015,19(2):209210.
[14] 田绿波,陈肖潇,贺黎铭,等.国境口岸入境人群丙型肝炎病毒的基因分型研究[J] .中华医学杂志,2015,95(12):903907.
[15] 武 荣,杜秀芳,王 坤,等.临汾市尧都区20102015年病毒性肝炎流行病学特征分析[J] .中国老年学杂志,2017,37(21):54465448.
[16] 王建利,孙蕊娟,胡晓卫.陕西咸阳地区无偿献血者抗HCV检测及RIBA确证分析[J] .陕西医学杂志,2017,46(11):16121614.

相似文献/References:

[1]邱邦东,徐全敏.抗HIV治疗艾滋病合并丙型肝炎对患者T淋巴细胞亚群、NK细胞及HIV载量的影响[J].陕西医学杂志,2019,(12):1619.
[2]李占山,宫思邈,廖 琦,等.G蛋白偶联胆汁酸受体1激动剂研究进展[J].陕西医学杂志,2025,54(3):413.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.025]
 LI Zhanshan,GONG Simiao,LIAO Qi,et al.Advances in the study of TGR5 agonists[J].,2025,54(9):413.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.025]

备注/Memo

备注/Memo:
*陕西省重点研发计划一般项目(2017SF234)
更新日期/Last Update: 2019-09-24